Quick answers
- What is Metronidazole used for?
- The FDA-approved label (Likmez, Saptalis Pharmaceuticals, LLC, April 18, 2025) says: “LIKMEZ is a nitroimidazole antimicrobial indicated for Trichomoniasis in adults Amebiasis in adults and pediatric patients Anaerobic Bacterial Infections in adults To reduce the development of drug-resistant bacteria and maintain the effectiveness of LIKMEZ and other antibacterial drugs, LIKMEZ should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. …” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Metronidazole have a boxed warning?
- Yes. The FDA label for Likmez has a boxed warning (“WARNING: POTENTIAL FOR CARCINOGENICITY”), the FDA’s strongest warning. Read it on the full label and ask your pharmacist.
- Is there a shortage of Metronidazole?
- The FDA drug shortage list shows “Current shortage” for a product of this medicine (updated October 21, 2026). Ask your pharmacist about alternatives.
- Has Metronidazole been recalled?
- FDA enforcement reports list 2 recalls of products of this medicine; the newest started January 21, 2016 (Class I). A recall usually concerns specific lots, not every product.
- Who makes Metronidazole?
- 65 companies list prescription products of Metronidazole in the FDA NDC Directory, including Bryant Ranch Prepack, Remedyrepack Inc. and A-S Medication Solutions.
What Metronidazole is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
LIKMEZ is a nitroimidazole antimicrobial indicated for Trichomoniasis in adults Amebiasis in adults and pediatric patients Anaerobic Bacterial Infections in adults To reduce the development of drug-resistant bacteria and maintain the effectiveness of LIKMEZ and other antibacterial drugs, LIKMEZ should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. …
— FDA label: Likmez, Saptalis Pharmaceuticals, LLC, effective April 18, 2025. Read the full label on DailyMed →
The FDA has 146 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Conditions named on the label
These condition names appear word for word in the label’s “Indications and Usage” text (matched with a reviewed table). Each page lists hospitals whose own websites name the condition.
Related medical specialties
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
This label has a boxed warning. Its heading: WARNING: POTENTIAL FOR CARCINOGENICITY
. Read it on the full label →
101 of 146 FDA labels for this medicine have a boxed warning.
Forms and how it is given
| Dosage forms | Tablet · Tablet, film coated · Gel · Cream · Injection, solution · Capsule · Lotion · Suspension · Tablet, film coated, extended release · Solution |
|---|---|
| Route | Oral · Topical · Vaginal · Intravenous |
| Prescription products | 177 in the FDA NDC Directory |
| Brand names | Metronidazole Vaginal, Metronidazole Vaginal Gel, Likmez, Vagizole, Noritate, Flagyl, Metronidazole Vaginal Gel, 0.75%, Nuvessa, Vandazole |
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| metronidazole 0.75% cream | Generic | $0.2594 per gram |
| metronidazole 0.75% gel | Generic | $0.1463–$0.1992 per gram 11 packages, lowest to highest |
| metronidazole 0.75% gel | Brand: Vandazole | $0.3462 per gram |
| metronidazole 0.75% lotion | Generic | $1.82 per mL |
| metronidazole 1% gel | Generic | $0.5597–$0.6328 per gram 8 packages, lowest to highest |
| metronidazole 100 mg/mL suspension | Brand: Likmez | $2.60–$2.60 per mL 2 packages, lowest to highest |
| metronidazole 250 mg tablet | Generic | $0.1079 per tablet |
| metronidazole 250 mg tablet, film coated | Generic | $0.1079 per tablet |
| metronidazole 375 mg capsule | Generic | $9.13 per capsule |
| metronidazole 500 mg tablet | Generic | $0.1045 per tablet |
| metronidazole 500 mg tablet, film coated | Generic | $0.1045 per tablet |
| metronidazole 65 mg/5 g gel | Brand: Nuvessa | $42.98 per gram |
| metronidazole 7.5 mg/mL lotion | Generic | $1.82 per mL |
NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- Bryant Ranch Prepack18 products
- Remedyrepack Inc.15 products
- A-S Medication Solutions9 products
- NuCare Pharmaceuticals, Inc.9 products
- PD-Rx Pharmaceuticals, Inc.5 products
- Alembic Pharmaceuticals Limited5 products
- Aurobindo Pharma Limited5 products
- Method Pharmaceuticals, LLC4 products
- Alembic Pharmaceuticals Inc.4 products
- Preferred Pharmaceuticals Inc.4 products
- Zydus Lifesciences Limited4 products
- Viona Pharmaceuticals Inc4 products
- Sun Pharmaceutical Industries, Inc.4 products
- Cosette Pharmaceuticals, Inc.4 products
- Encube Ethicals, Inc.3 products
- Mayne Pharma Inc.3 products
- Northwind Health Company, LLC3 products
- Proficient Rx LP3 products
- Chartwell RX, LLC3 products
- Unichem Pharmaceuticals (USA), Inc.2 products
- AvPAK2 products
- Coupler LLC2 products
- Saptalis Pharmaceuticals, LLC.2 products
- Cardinal Health 107, LLC2 products
- Asclemed USA, Inc.2 products
- Teva Pharmaceuticals USA, Inc.2 products
- Golden State Medical Supply, Inc.2 products
- PharmPak, Inc.2 products
- Baxter Healthcare Corporation2 products
- Amici Pharma, Inc.2 products
- Cadila Pharmaceuticals Limited2 products
- Major Pharmaceuticals2 products
- Alembic Labs LLC2 products
- American Health Packaging2 products
- BluePoint Laboratories2 products
- Rising Pharma Holdings, Inc.2 products
- Fougera Pharmaceuticals, LLC2 products
- Redpharm Drug2 products
- Kanchan Healthcare Inc2 products
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.2 products
- St. Mary's Medical Park Pharmacy2 products
- Sportpharm LLC1 product
- iNutrition LLC1 product
- Bausch Health US, LLC1 product
- Direct_Rx1 product
- Prasco Laboratories1 product
- Pfizer Laboratories Div Pfizer Inc1 product
- Civica, Inc.1 product
- WG Critical Care, LLC1 product
- Gland Pharma Limited1 product
- Sagent Pharmaceuticals1 product
- Quality Care Products, LLC1 product
- Glenmark Pharmaceuticals Inc., USA1 product
- Amneal Pharmaceuticals Private Limited1 product
- Oceanside Pharmaceuticals1 product
- Exeltis USA, Inc.1 product
- Upsher-Smith Laboratories, LLC1 product
- Hospira, Inc.1 product
- Solaris Pharma Corporation1 product
- Kesin Pharma Corporation1 product
- RedPharm Drug, Inc.1 product
- Henry Schein, Inc.1 product
- NorthStar Rx LLC1 product
- Padagis Israel Pharmaceuticals Ltd1 product
- B. Braun Medical Inc.1 product
FDA approval history
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Application | Sponsor | Approved | Later changes approved |
|---|---|---|---|
| NDA018657 FLAGYL I.V. RTU IN PLASTIC CONTAINER | Baxter Hlthcare | December 24, 1981 | 37, latest June 24, 2025 2025: Labeling · 2025: Labeling · 2024: Labeling |
| NDA018900 METRO I.V. IN PLASTIC CONTAINER | B Braun | September 29, 1983 | 25, latest April 23, 2026 2026: Labeling · 2025: Labeling · 2024: Labeling |
| NDA020208 METROGEL-VAGINAL | Bausch | August 17, 1992 | 8, latest April 17, 2002 2002: Manufacturing (CMC) · 1997: Labeling · 1997: Efficacy |
| NDA020334 FLAGYL | Pfizer | May 3, 1995 | 10, latest July 8, 2024 2024: Labeling · 2023: Labeling · 2021: Labeling |
| NDA020531 METROCREAM | Galderma Labs LP | September 20, 1995 | 1, latest August 30, 2002 2002: Manufacturing (CMC) |
| NDA020743 NORITATE | Bausch | September 26, 1997 | 3, latest December 5, 2014 2014: Manufacturing (CMC) · 2004: Manufacturing (CMC) · 2003: Labeling |
| NDA020901 METROLOTION | Galderma Labs LP | November 24, 1998 | 3, latest January 7, 2015 2015: Labeling · 2004: Labeling · 2002: Manufacturing (CMC) |
| NDA021789 METROGEL | Galderma Labs LP | June 30, 2005 | 9, latest November 22, 2023 2023: Labeling · 2022: Labeling · 2022: Labeling |
| NDA021806 VANDAZOLE | Teva Pharms | May 20, 2005 | 4, latest February 11, 2021 2021: Labeling · 2014: Manufacturing (CMC) · 2011: Labeling |
| NDA205223 NUVESSA | Alembic Therap | March 24, 2014 | 4, latest February 25, 2022 2022: Labeling · 2021: Labeling · 2018: Efficacy |
| NDA216755 LIKMEZ | Saptalis Pharms | September 22, 2023 | 3, latest February 28, 2025 2025: Labeling · 2024: Labeling · 2024: Labeling |
Generic approvals (37)
- ANDA070027Teva Pharms USA · December 6, 1984
- ANDA070033Pliva · December 6, 1984
- ANDA070772Innogenix · July 16, 1986
- ANDA076522Chartwell Rx · January 29, 2004
- ANDA076408Fougera Pharms · May 28, 2004
- ANDA077197Fougera Pharms · May 24, 2006
- ANDA077547Encube · July 13, 2006
- ANDA077819Taro · July 18, 2006
- ANDA077549Cosette Pharms Nc · December 19, 2007
- ANDA079067Alembic Pharms Ltd · March 13, 2009
- ANDA079065Alembic · June 23, 2009
- ANDA090222Alembic · May 5, 2010
- ANDA078178Cosette Pharms Nc · January 19, 2011
- ANDA203458Unichem · January 22, 2014
- ANDA203974Aurobindo Pharma Ltd · May 29, 2015
- ANDA205245Somerset Theraps LLC · September 23, 2015
- ANDA206560Cadila · November 16, 2016
- ANDA204651Taro · March 14, 2017
- ANDA208681Alembic · June 20, 2017
- ANDA209794Cadila Pharms Ltd · December 12, 2017
- ANDA206191Inforlife · February 25, 2019
- ANDA211786Padagis Israel · July 2, 2019
- ANDA212435Gland · August 3, 2020
- ANDA212646Alembic · September 3, 2021
- ANDA213648Amvika · October 14, 2021
- ANDA215794Glenmark Pharms Ltd · January 27, 2022
- ANDA216692Cosette Pharms Nc · January 23, 2023
- ANDA217128Zydus Lifesciences · April 21, 2023
- ANDA217665Amneal · May 24, 2023
- ANDA215610Encube · June 16, 2023
- ANDA216323Cosette Pharms Nc · July 12, 2023
- ANDA216795Encube · March 18, 2024
- ANDA218941Aurobindo Pharma Ltd · October 15, 2024
- ANDA216750Sciegen Pharms · December 31, 2024
- ANDA219295Aurobindo Pharma Ltd · July 9, 2025
- ANDA220095Zydus Lifesciences · February 13, 2026
- ANDA218485Aurobindo Pharma Ltd · September 25, 2026
Shortage status
Current shortage · updated October 21, 2026 · first posted January 13, 2022
| Product | Metronidazole In Plastic Container, Injection, 500 mg/100 mL (NDC 47335-993-01) |
|---|---|
| Availability | Unavailable |
| Reason given | Discontinuation of the manufacture of the drug |
| Company | Gland Pharma Limited |
Ask your pharmacist whether your product is affected and what the options are.
Recalls
From FDA enforcement reports, matched by the product’s NDC code. A recall usually covers specific lots only: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
January 21, 2016 · Class I · Terminated · D-0863-2016
Presence of Particulate Matter: identified as a cloth fiber.
Metronidazole Injection USP, 500 mg per 100 mL (5 mg/mL), 100mL Sterile Single Dose Container bag, Rx only, Baxter USA, Product Code 2B3421, NDC 0338-1055-48. — Baxter Healthcare Corp.
-
May 21, 2013 · Class II · Terminated · D-629-2013
Lack of Assurance of Sterility: Specific lot numbers of these products have been identified for potential administration port leakage. The potential for leakage is the result of a manufacturing issue which occurred during the sealing of the closure assembly at the administration port.
Metronidazole Injection USP, RTU, 500 mg/100mL in Viaflex Plus Container, Baxter, Deerfield, IL 60015, NDC 0338-1055-48 — Baxter Healthcare Corp.
What do the recall classes mean?
Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).
Official identifiers
| RxCUI (RxNorm) | 142046, 199055, 213120, 242736, 311678, 311679, 311680, 311681, 311683, 314106 … (+9) |
|---|---|
| SPL set ID of the quoted label | e20c14eb-5361-4a93-ab46-a7bd9aeb9b98 |
| FDA labels (SPL) | 146 |
| FDA applications | NDA018657, NDA018900, NDA020208, NDA020334, NDA020531, NDA020743, NDA020901, NDA021789, NDA021806, NDA205223, NDA216755, 37 ANDA |
| Active ingredients (FDA) | METRONIDAZOLE |
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — Likmez, Saptalis Pharmaceuticals, LLC, effective April 18, 2025; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →